CED News

« CED Now Accepting Applications to Present at Venture 2002 | Main | NetIQ Ranks 12th on Bloomberg's List of the 100 Fastest Growing Tech Companies »

Paradigm to Acquire Celera Genomic's AgGen in $2.1 Million Deal

In a deal worth $2.1 million, Paradigm Genetics Inc. (Nasdaq:PDGM) will acquire the the agricultural genomics business of Celera Genomics (NYSE:CRA). The Research Triangle Park-based company will become the exclusive marketing partner to provide Celera services to the plant-based agriculture industry. Upon closing of Paradigm's acquisition of the Celera's AgGen genomics and genotyping business, which is subject to customary conditions, Paradigm's new business unit will be named ParaGen. As part of the transaction, Celera will receive 422,459 shares of Paradigm common stock and will share future service revenue with Paradigm. Financial details of the marketing partnership were not disclosed. www.paragen.com

What Members are Saying

"CED has provided entrepreneurs like myself with an effective way to network and gather valuable information and meet other business leaders in the Research Triangle." -- Scot Wingo, President and CEO, ChannelAdvisor Corp.